Tokyo Tape
Sign in
← Sumitomo Chemical

Half-year report · Q2

4005.TEDINET S100UN1U
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥1.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥2.45T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.19T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥121.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income−¥133.7bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax−¥30.5bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥462.8bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥103.8bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)−¥6.5bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥311.8bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥76.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥20.3bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income−¥465.4bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income−¥107.0bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥3.72Tat 2024-09-30Cons.Assets IFRS
Total assets¥3.93Tat 2024-03-31Cons.Assets IFRS
Total assets¥4.38Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.63Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥2.77Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥1.09Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.16Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.55Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.49Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥909.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥965.8bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥273.4bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥217.4bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥277.7bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥305.8bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥63.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥51.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥115.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥74.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥112.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥79.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥75.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥49.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥140.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-3.992024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-190.692023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-46.692023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
Equity ratio24.5%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio27.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥78.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥41.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥37.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥15.7bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥50.2bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥50.2bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥10.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥147.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥138.8bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥405.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥403.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30−¥36.6bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥239.5bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥238.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥13.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2024-04-01 → 2024-09-30¥224.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2024-04-01 → 2024-09-30¥224.3bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥235m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2024-04-01 → 2024-09-30¥37.5bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥195.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥195.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥470m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.21T
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.20T
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.0bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥23.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥76.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥34.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥41.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥4.3bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥56.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥56.0bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥7.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥159.8bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥149.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.5bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2023-04-01 → 2023-09-30¥393.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2023-04-01 → 2023-09-30¥390.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥2.8bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥44.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥243.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥241.2bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1.8bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30−¥7.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2023-04-01 → 2023-09-30¥203.9bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2023-04-01 → 2023-09-30¥203.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥220m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2023-04-01 → 2023-09-30¥17.8bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥166.9bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥166.9bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥65.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥1.17T
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.15T
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥14.7bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥93.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 919
ItemContextValueUnit
Other comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-43045000000JPY
Other comprehensive income IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember-1725000000JPY
Other comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-44770000000JPY
Other comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-5377000000JPY
Other comprehensive income IFRSCurrentYTDDuration-50147000000JPY
Comprehensive income IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-98000000JPY
Comprehensive income IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-27830000000JPY
Comprehensive income IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-43045000000JPY
Comprehensive income IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember-1725000000JPY
Comprehensive income IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-51297000000JPY
Comprehensive income IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-19135000000JPY
Comprehensive income IFRSCurrentYTDDuration-70432000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Issuance of new shares ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Issuance of new shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Issuance of new shares ss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Issuance of new shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember240000000JPY
Issuance of new shares ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Issuance of new shares ss IFRSCurrentYTDDuration240000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-3000000JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration-3000000JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Disposal of treasury shares ss IFRSCurrentYTDDuration0JPY
Dividends ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-4908000000JPY
Dividends ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-2797000000JPY
Dividends ss IFRSCurrentYTDDuration-7705000000JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember－JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember28000000JPY
Disposal of subsidiaries ss IFRSCurrentYTDDuration28000000JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transactions with non controlling interests ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass